科兴peer reviewed phase 3 data在哪不谈政治 只谈科学
科兴只发了phase1,2的paper:https://www.thelancet.com/article/S1473-3099(20)30843-4/fulltext
"No Phase 3 study data on the vaccine has yet been published in peer-reviewed journals."
为啥拖了这么久发不出phase 3的paper
国药:"The WHO’s approval of Sinopharm before the publication of peer-reviewed data reflected a measure of desperation "
辉瑞paper:https://www.nejm.org/doi/full/10.1056/nejmoa2034577
莫德纳paper: https://www.nejm.org/doi/full/10.1056/nejmoa2035389
三期结果都公布了啊
科兴:
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3822780
国药(三期interim报告):
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2780562
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3822780
国药(三期interim报告):
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2780562